Summit Partners Public Asset Management, LLC Moderna, Inc. Transaction History
Summit Partners Public Asset Management, LLC
- $3.3 Billion
- Q1 2025
A detailed history of Summit Partners Public Asset Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Summit Partners Public Asset Management, LLC holds 30,000 shares of MRNA stock, worth $830,400. This represents 0.18% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$830,400% of portfolio
0.18%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MRNA
# of Institutions
875Shares Held
255MCall Options Held
24MPut Options Held
31.3M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.12 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$708 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$691 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$492 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$206 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...